Frank Petosa Named to Plaintiffs' Steering Committee in 'Low T' MDL

Morgan & Morgan is pleased to announce that Frank
Petosa, an attorney with
the firm’s complex litigation group, has been appointed to the
plaintiffs’ steering committee (PSC) in the multidistrict litigation
(MDL) involving harmful side effects allegedly caused by controversial
low testosterone medications, commonly referred to as “Low
T” therapies.

The Testosterone Replacement Therapy MDL will streamline and expedite
the legal process for men alleging injury as a result of using
testosterone and the PSC will fight to ensure that they receive the
justice they deserve.

“Testosterone manufacturers, seeking to increase their profits, heavily
promoted testosterone as a safe and effective way for men to re-discover
their youth while the companies made billions of dollars. However, they
were aware that testosterone is for a limited percentage of men and that
it can cause men to suffer heart attacks, strokes and blood clots,”
Petosa said in a statement. “As a result of the greed of testosterone
manufacturers, men have suffered cardiovascular injuries and died. I and
the other members of the PSC will have the privilege of holding
testosterone manufacturers accountable for their conduct and responsible
for causing men to suffer cardiovascular injuries and death from using
testosterone.”

In June, the U.S. Judicial Panel on Multidistrict Litigation (JPML)
consolidated into a single judicial proceeding all federal lawsuits
filed nationwide involving the dangerous side effects of Low T
therapies. The Honorable Matthew F. Kennelly of the Eastern District of
Illinois will preside over the litigation. While class action lawsuits
generally involve one person representing the interests of an entire
group, or class, of people, the federal court system will create an MDL
when plaintiffs across the country file numerous lawsuits alleging
similar injuries from a defective product or dangerous prescription
drug.

“The Testosterone Replacement Therapy (TRT) MDL will streamline and
expedite the legal process for men alleging injury as a result of using
testosterone and the PSC will fight to ensure that they receive the
justice they deserve,” Petosa said.

The attorneys serving on the PSC are responsible for, among other
things, conducting pretrial proceedings and gathering evidence to help
expedite the litigation.

Many of the patients who have used Low T products experienced harmful
side effects, including heart attacks, strokes, deep vein thrombosis,
pulmonary embolisms, and other serious conditions. The lawsuits allege
that the makers of six popular low testosterone therapies failed to warn
patients and doctors of these risks.

“Morgan & Morgan is dedicated to protecting and working for the
people, not the powerful,” Petosa said. “My position on the plaintiffs’
steering committee will allow me to fight for men and the families
harmed by the greed of testosterone manufacturers.”